Capricor Therapeutics (CAPR) Q1 2025 Earnings

19MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.38
-0.29
-0.2
-0.11

Details

Expected EPS
-0.17
Actual EPS
-0.16
Surprise EPS
0.01
Surprise Percent
+5.88%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.16 per share for Q1 2025.

0 Comments

Share your thoughts